Michael Spellacy - 09 Jan 2023 Form 4/A - Amendment Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
17 Jan 2023, 15:16:51 UTC
Date Of Original Report
11 Jan 2023
Previous filing
20 Sep 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +5,001 +22% $0.000000 28,107 09 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The RSUs will vest in full on the earlier of June 16, 2023 or the date of the 2023 annual meeting of stockholders of the issuer.
F2 This Form 4 is being amended solely to correct the number of RSUs granted, which was inadvertently reported as 5,235 on the original Form 4 filing due to a clerical error. The correct number of RSUs is 5,001.